Every open market buy and sale of CytomX Therapeutics, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $1.2M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when CTMX insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an CTMX officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every CTMX insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Christopher OgdenCFO | Sale | 1,624 | $3.05 | $5K | 295,324 | Jun 17Form 4 |
| Mar 17, 2026 | Christopher OgdenCFO | Sale | 19,323 | $6.42 | $124K | 296,948 | Mar 19Form 4 |
| Mar 17, 2026 | Marcia BelvinSVP, Chief Scientific Officer | Sale | 31,492 | $6.42 | $202K | 300,760 | Mar 19Form 4 |
| Mar 17, 2026 | Sean A. McCarthyCEO | Sale plan | 118,969 | $6.42 | $764K | 1,078,922 | Mar 19Form 4 |
| Mar 17, 2026 | Yu-Waye ChuChief Medical Officer | Sale | 21,279 | $6.42 | $137K | 189,446 | Mar 19Form 4 |
| Nov 6, 2025 | Sean A. McCarthyCEO | Sale plan | 101,793 | $4.54 | $462K | 987,891 | Nov 10Form 4 |
| Jun 16, 2025 | Sean A. McCarthyCEO | Sale | 55,511 | $2.69 | $149K | 1,089,684 | Jun 17Form 4 |
| Jun 16, 2025 | Marcia BelvinSVP, Chief Scientific Officer | Sale | 13,884 | $2.69 | $37K | 272,252 | Jun 17Form 4 |
| Jun 16, 2025 | Christopher OgdenCFO | Sale | 12,255 | $2.72 | $33K | 226,271 | Jun 17Form 4 |
| Mar 18, 2025 | Marcia BelvinSVP, Chief Scientific Officer | Sale | 19,512 | $0.60 | $12K | 248,636 | Mar 20Form 4 |
| Mar 18, 2025 | Lloyd A RowlandGeneral Counsel | Sale | 10,203 | $0.60 | $6K | 120,594 | Mar 20Form 4 |
| Mar 18, 2025 | Yu-Waye ChuChief Medical Officer | Sale | 4,025 | $0.60 | $2K | 135,725 | Mar 20Form 4 |
| Mar 18, 2025 | Christopher OgdenCFO | Sale | 8,551 | $0.60 | $5K | 201,026 | Mar 20Form 4 |
| Mar 18, 2025 | Sean A. McCarthyCEO | Sale | 37,656 | $0.60 | $23K | 995,195 | Mar 20Form 4 |
CTMX insider trading FAQ
Are CTMX insiders buying or selling?
Insiders are only selling over the last 12 months. 0 insiders bought $0 of CTMX on the open market in 0 trades, and 4 sold $1.2M in 5 trades, 62% of that under pre-arranged trading plans.
When did an CTMX insider last buy shares?
There has been no open market insider purchase of CTMX in the last two years.
When did an CTMX insider last sell shares?
Christopher Ogden (CFO) sold 1,624 shares for $5K on Jun 15, 2026.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
